Etoposide
- Product NDC
- 0143-9511
- 11-digit product format
- 001439511
- Labeler code
- 0143
- Product ID
- 0143-9511_15cf77cf-4207-463d-b6ef-16163db5afb9
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Etoposide
- Dosage form
- INJECTION
- Route
- INTRAVENOUS
- Labeler
- Hikma Pharmaceuticals USA Inc.
- Application
- ANDA074290
- Marketing category
- ANDA
- Marketing start
- 1997-02-01
- Substance
- ETOPOSIDE
- Active strength
- 20 mg/mL
- Pharmacologic classes
- Topoisomerase Inhibitor [EPC], Topoisomerase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Etoposide
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| ETOPOSIDE | 20 mg/mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 6PLQ3CP4P3 |
| Rxcui | 310248 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 0143-9511-01 | Etoposide | 25 mL in 1 VIAL | INJECTION | 25 | | 5 |
| 0143-9511-01 | Etoposide | 1 in 1 BOX, UNIT-DOSE | INJECTION | 1 | | 5 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 0143-9511 | ETOPOSIDE INJECTION [HIKMA PHARMACEUTICALS USA INC.] | 5 | Current NDC, Legacy NDC, 2 package rows | 20230915_6dfedeff-a807-4405-a482-2f7109ad31c9.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0143-9511-01 | 00143951101 | 1 VIAL in 1 BOX, UNIT-DOSE (0143-9511-01) / 25 mL in 1 VIAL | 1 vial | 2017-10-23 | 0000-00-00 | No | No | Current |